Amanda Charlton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amanda Charlton has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Nicole Graf
Histopathology Department, The Children's Hospital at Westmead Westmead and University of Sydney Sydney NSW Australia
2 shared publications - Albert Chetcuti
Tumour Bank, The Children's Cancer Research Unit, Kid's Research Institute, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia
1 shared publication - Anthony Henwood
Histopathology Department, The Children's Hospital at Westmead, Sydney, Australia
1 shared publication Bradley Webster
1 shared publicationDaniel R. Catchpoole
The Kids Research Institute, The Children’s Hospital at Westmead
1 shared publication- Daniel Robin Catchpoole
Biomedical Research, Children's Cancer Research Unit, Kids Research, Sydney Children's Hospital Network, Westmead, NSW, Australia
1 shared publication
Latest Publications
- 14 April 2018
- Published by Springer Nature
- p. 57-71
Patched Completed Local Binary Pattern is an Effective Method for Neuroblastoma Histological Image Classification
- 14 April 2018
- Published by Springer Nature
- p. 57-71
Patched Completed Local Binary Pattern is an Effective Method for Neuroblastoma Histological Image Classification
- Open Access
Can Archival Tissue Reveal Answers to Modern Research Questions?: Computer-Aided Histological Assessment of Neuroblastoma Tumours Collected over 60 Years
Despite neuroblastoma being the most common extracranial solid cancer in childhood, it is still a rare disease. Consequently, the unavailability of tissue for research limits the statistical power of studies. Pathology archives are possible sources of rare tissue, which, if proven to remain consistent over time, could prove useful to research of rare disease types. We applied immunohistochemistry to investigate whether long term storage caused any changes to antigens used diagnostically for neuroblastoma. We constructed and quantitatively assessed a tissue microarray containing neuroblastoma archival material dating between 1950 and 2007. A total of 119 neuroblastoma tissue cores were included spanning 6 decades. Fourteen antibodies were screened across the tissue microarray (TMA). These included seven positive neuroblastoma diagnosis markers (NB84, Chromogranin A, NSE, Ki-67, INI1, Neurofilament Protein, Synaptophysin), two anticipated to be negative (S100A, CD99), and five research antibodies (IL-7, IL-7R, JAK1, JAK3, STAT5). The staining of these antibodies was evaluated using Aperio ImageScope software along with novel pattern recognition and quantification algorithms. This analysis demonstrated that marker signal intensity did not decrease over time and that storage for 60 years had little effect on antigenicity. The construction and assessment of this neuroblastoma TMA has demonstrated the feasibility of using archival samples for research.
Open AccessCan Archival Tissue Reveal Answers to Modern Research Questions?: Computer-Aided Histological Assessment of Neuroblastoma Tumours Collected over 60 Years
Despite neuroblastoma being the most common extracranial solid cancer in childhood, it is still a rare disease. Consequently, the unavailability of tissue for research limits the statistical power of studies. Pathology archives are possible sources of rare tissue, which, if proven to remain consistent over time, could prove useful to research of rare disease types. We applied immunohistochemistry to investigate whether long term storage caused any changes to antigens used diagnostically for neuroblastoma. We constructed and quantitatively assessed a tissue microarray containing neuroblastoma archival material dating between 1950 and 2007. A total of 119 neuroblastoma tissue cores were included spanning 6 decades. Fourteen antibodies were screened across the tissue microarray (TMA). These included seven positive neuroblastoma diagnosis markers (NB84, Chromogranin A, NSE, Ki-67, INI1, Neurofilament Protein, Synaptophysin), two anticipated to be negative (S100A, CD99), and five research antibodies (IL-7, IL-7R, JAK1, JAK3, STAT5). The staining of these antibodies was evaluated using Aperio ImageScope software along with novel pattern recognition and quantification algorithms. This analysis demonstrated that marker signal intensity did not decrease over time and that storage for 60 years had little effect on antigenicity. The construction and assessment of this neuroblastoma TMA has demonstrated the feasibility of using archival samples for research.